Guided meditation during radiation therapy for brain tumors
An Interventional Trial Using Guided Meditation During Radiation Therapy for Brain Tumors
This study tests if listening to guided meditation during radiation therapy can help reduce anxiety in patients with brain tumors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Utah Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Salt Lake City, Utah) |
| Trial ID | NCT06165653 on ClinicalTrials.gov |
What this trial studies
This interventional treatment assesses the effect of guided meditation on anxiety levels in patients undergoing radiation therapy for brain tumors. Participants will listen to a 5-minute audio-recorded mindfulness practice during each radiation session. The study compares the anxiety levels of those receiving the mindfulness intervention to those receiving standard care without any intervention. The goal is to determine if this mindfulness approach can effectively reduce acute anxiety during treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a radiologically confirmed brain tumor who are eligible for radiation treatment.
Not a fit: Patients with active suicidal ideation, unstable illnesses, or those who have previously received radiation therapy to the brain may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety for patients undergoing radiation therapy for brain tumors.
How similar studies have performed: While the specific combination of guided meditation during radiation therapy is novel, similar mindfulness interventions have shown promise in reducing anxiety in other medical settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant aged ≥ 18 years. * Radiologically confirmed tumor of the brain. Note: Participants may have tumor resected after diagnosis. * Eligible to undergo radiation treatment for brain tumor for 25-33 treatments. * Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment. * Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2. * MoCA mini score ≥ 11 * Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines. Exclusion Criteria: * Active suicidal ideation or active psychotic state in the opinion of the investigator. * An unstable illness that, in the opinion of the investigator, would interfere with study treatment. * Prior radiation therapy to the brain. * Inability to understand and/or speak the English language.
Where this trial is running
Salt Lake City, Utah
- Huntsman Cancer Institute — Salt Lake City, Utah, United States (Recruiting)
Study contacts
- Principal investigator: Lindsay Burt, MD — Huntsman Cancer Institute/ University of Utah
- Study coordinator: Rachel Kingsford
- Email: rachel.kingsford@hci.utah.edu
- Phone: 801-585-0115
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.